GeneTherapy.ISTH.org - Gene Therapy Latest News

FDA Agrees to Phase 1 Trial of ET3, Gene Therapy for Hemophilia A

FDA Agrees to Phase 1 Trial of ET3, Gene Therapy for Hemophilia A

27 May 2020

Hemophilia A Gene Therapy, AMT-180, Continues to Show Activity, Safety in Animals

Hemophilia A Gene Therapy, AMT-180, Continues to Show Activity, Safety in Animals

15 May 2020

3 Hemophilia B Patients Report AMT-060 Gene Therapy Gave Them Normalcy

3 Hemophilia B Patients Report AMT-060 Gene Therapy Gave Them Normalcy

18 May 2020

BioMarin’s Gene Therapy for Hemophilia A Remains on Track for US Approval

BioMarin’s Gene Therapy for Hemophilia A Remains on Track for US Approval

13 May 2020

Request for Proposals: Artificial Intelligence/Machine Learning Research in Hemophilia
17 April 2020
Phase 3 Trial of AMT-061 Gene Therapy for Hemophilia B Exceeds Target Dosing
27 March 2020
Hemophilia Gene Therapy Knowledge and Perceptions: Results of an International Survey
19 March 2020
Gene & Anti-TFPI Therapies in Hemophilia: Competitive Grant Program
18 March 2020

I agree with the Terms and conditions and the Privacy policy

About

Supported by educational grants from BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, and uniQure, Inc

Essential SSL